Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Lucas Widmer"'
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.
Autor:
Linard Filli, Pascal Hostettler, Katja Reuter, Dominik Straumann, Lucas Widmer, Angela Ehrhardt, Jens A. Petersen
Publikováno v:
Scientific Reports
Falls are common in patients with neurological disorders and are a primary cause of injuries. Nonetheless, fall-associated gait characteristics are poorly understood in these patients. Objective, quantitative gait analysis is an important tool to ide
Autor:
Lucas Widmer, Elisabeth Oppliger Leibundgut, Daniela Baertschi, D. Helbling, Axel Madlung, H. Sun, F. Bosman, Markus Borner, R. Burkhard, Daniel Rauch, Ralph Winterhalder, Dieter Koeberle, György Bodoky, Beat Gloor, Piercarlo Saletti, O. Gautschi, Pu Yan, S. Bougel, Jean Benhattar
Publikováno v:
Helbling, D.; Bodoky, G.; Gautschi, O.; Sun, H.; Bosman, F.; Gloor, Beat; Burkhard, R.; Winterhalder, R.; Madlung, Axel; Rauch, Daniel; Saletti, P.; Widmer, L.; Borner, M.; Baertschi, D.; Yan, P.; Benhattar, J.; Leibundgut, Elisabeth O.; Bougel, S.; Koeberle, D. (2013). Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Annals of oncology, 24(3), pp. 718-725. Oxford University Press 10.1093/annonc/mds519
BACKGROUND We conducted a randomized, phase II, multicenter study to evaluate the anti-epidermal growth factor receptor (EGFR) mAb panitumumab (P) in combination with chemoradiotherapy (CRT) with standard-dose capecitabine as neoadjuvant treatment fo
Autor:
Lucas Widmer, Thomas Ruhstaller, Mathew Simcock, R. A. Popescu, Doris Lanz, Roger von Moos, Catrina Uhlmann, Dieter Köberle, Arnaud Roth, Richard Cathomas
Publikováno v:
Onkologie, Vol. 33, No 6 (2010) pp. 295-299
BACKGROUND: A phase I multicentre trial was conducted to define the recommended dose of capecitabine in combination with oxaliplatin and irinotecan (OCX) in metastatic colorectal cancer. PATIENTS AND METHODS: Patients with performance status (PS) < 2
Autor:
Michael Pfreundschuh, Susanne Albrecht, Gunter Schuch, Thomas Hany, Wolfgang Schmitt, Thorsten Fischer, Martin Pölcher, Qingyuan Zhang, Michael Zünd, Niels Murawski, George H. Sakorafas, Karl T.M. Schneider, Sabine Balmer-Majno, Wenjie Ma, Jingxuan Wang, Ina Thöm, Nikolaus de Gregorio, Spiros Christodoulou, Thomas Kubin, Christos Lappas, Rolf Kreienberg, Isabell Witzel, Shu Zhao, Egbert Nitzsche, Zhengyan Yu, Christine Wulff, Carsten Bokemeyer, Peter Brauchli, Antonia Dimitrakopoulou-Strauss, Clemens Caspar, Dieter Köberle, Gisela Walgenbach-Bruenagel, Michael Braun, Roger von Moos, Corinne Cescato-Wenger, Thorleif Etgen, Bernd Klaeser, Ruediger Hein, Nikolaos Antoniou, Eva Wardelmann, Christian Rudlowski, Shi Jin, Reinhard Büttner, Eckart Laack, Thomas Ruhstaller, Hanne Stensheim, Athanasios N. Chalazonitis, Manuel Debald, Nina Gottschalk, Ludwig G. Strauss, Flora Zagouri, Claudia Rogers, Meletios-Athanasios Dimopoulos, Aristotle Bamias, Jan C. Schuller, Maria Papaefthimiou, Birte Andritzky, Tobias Höller, Volker R. Jacobs, Bernhard C. Pestalozzi, Walther Kuhn, Stephanie Pildner von Steinburg, Georg Weidenhöfer, Axel Sauerwald, Lucas Widmer, Michael Safioleas, Matthias Wolfgarten, Yongzhi Zhuang, Dieter K. Hossfeld
Publikováno v:
Onkologie. 32:IX-XIV
Autor:
Antonia Dimitrakopoulou-Strauss, Eckart Laack, Christine Wulff, Karl Schneider, Bernhard C. Pestalozzi, Eva Wardelmann, Hanne Stensheim, Maria Papaefthimiou, Birte Andritzky, Shu Zhao, Nikolaus de Gregorio, Michael Braun, Roger von Moos, Clemens B. Caspar, Athanasios N. Chalazonitis, Tobias Höller, Volker R. Jacobs, Niels Murawski, Spiros Christodoulou, Peter Brauchli, Yongzhi Zhuang, Susanne Albrecht, Nikolaos Antoniou, Jingxuan Wang, Wolfgang Schmitt, Zhengyan Yu, George H. Sakorafas, Nina Gottschalk, Flora Zagouri, Claudia Rogers, Michael Zünd, Axel Sauerwald, Carsten Bokemeyer, Aristotle Bamias, Thomas Kubin, Jan C. Schuller, Ruediger Hein, Corinne Cescato-Wenger, Dieter Köberle, Georg Weidenhöfer, Wenjie Ma, Gisela Walgenbach-Bruenagel, Dieter K. Hossfeld, Meletios-Athanasios Dimopoulos, Bernd Klaeser, Ludwig G. Strauss, Martin Pölcher, Isabell Witzel, Manuel Debald, Rolf Kreienberg, Ina Thöm, Sabine Balmer-Majno, Thorsten Fischer, Egbert Nitzsche, Christos Lappas, Shi Jin, Reinhard Büttner, Thorleif Etgen, Matthias Wolfgarten, Thomas F. Hany, Lucas Widmer, Michael Safioleas, Qingyuan Zhang, Stephanie Pildner von Steinburg, Gunter Schuch, Michael Pfreundschuh, Christian Rudlowski, Thomas Ruhstaller, Walther Kuhn
Publikováno v:
Onkologie. 32:III-VIII
Autor:
Rémi Legay, Johannes Lukaschek, Hanspeter Honegger, Lucas Widmer, Dominik Maurer, Martin Nufer, Myriam Malet-Martino, Robert Martino, Maximilian Asanger
Publikováno v:
Journal of Clinical Oncology. 22:5022-5025
Autor:
Susanne Albrecht, Michael Zünd, Nikolaus de Gregorio, Yongzhi Zhuang, Bernd Klaeser, Ludwig G. Strauss, Thomas Hany, Eckart Laack, Nina Gottschalk, Peter Brauchli, Egbert Nitzsche, Spiros Christodoulou, Axel Sauerwald, Rolf Kreienberg, Dieter Köberle, Matthias Wolfgarten, Gisela Walgenbach-Bruenagel, Zhengyan Yu, Gunter Schuch, Christine Wulff, Flora Zagouri, Claudia Rogers, Niels Murawski, Thorleif Etgen, Corinne Cescato-Wenger, Lucas Widmer, Karl T.M. Schneider, Jingxuan Wang, Eva Wardelmann, Michael Pfreundschuh, Michael Safioleas, Sabine Balmer-Majno, Wolfgang Schmitt, Hanne Stensheim, George H. Sakorafas, Thomas Kubin, Aristotle Bamias, Antonia Dimitrakopoulou-Strauss, Roger von Moos, Martin Pölcher, Christian Rudlowski, Ina Thöm, Georg Weidenhöfer, Dieter K. Hossfeld, Tobias Höller, Volker R. Jacobs, Clemens Caspar, Thomas Ruhstaller, Christos Lappas, Birte Andritzky, Stephanie Pildner von Steinburg, Walther Kuhn, Ruediger Hein, Bernhard C. Pestalozzi, Wenjie Ma, Maria Papaefthimiou, Isabell Witzel, Thorsten Fischer, Qingyuan Zhang, Shu Zhao, Michael Braun, Meletios-Athanasios Dimopoulos, Jan C. Schuller, Shi Jin, Reinhard Büttner, Athanasios N. Chalazonitis, Nikolaos Antoniou, Manuel Debald, Carsten Bokemeyer
Publikováno v:
Onkologie. 32:785-787
Publikováno v:
Blood. 88:3166-3175
The use of ex vivo expanded CD34-selected hematopoietic progenitor cells (HPCs) for autologous stem cell support or gene therapy is a major area of research and is likely to increase in the future. At present, little is known about the fate of contam